IIOT-OXYS, Inc. Announces Chandran Seshagiri Successfully Completes CTO Term, Continues as Advisory Board Chairman
IIOT-OXYS, Inc. (OTC PINK: ITOX) recently announced the successful completion of Chandran Seshagiri, Ph.D.’s interim CTO role. He will now serve as Advisory Board Chairman, continuing to guide algorithm development. CEO Cliff Emmons will temporarily assume CTO duties as the company finalizes a contract with a new candidate, emphasizing a shift towards Artificial Intelligence and Machine Learning. The firm has secured Non-Disclosure Agreements and is building on prior collaborations, aiming to expand its presence in smart manufacturing and structural health monitoring.
- Chandran Seshagiri's continuation as Advisory Board Chairman ensures ongoing technical leadership.
- The company is in final negotiations for a new CTO, focusing on AI and ML integration.
- Successful pilot projects with a Fortune 500 Pharma company and a state DOT open new business opportunities.
- Growing sales and marketing efforts are expanding the company’s market presence.
- The interim nature of the CTO position raises concerns about leadership continuity until a permanent successor is appointed.
CAMBRIDGE, MA / ACCESSWIRE / July 7, 2021 / IIOT-OXYS, Inc. (OTC PINK:ITOX) announced Chandran Seshagiri, Ph.D., successfully completed his interim CTO term, and will continue as Advisory Board Chairman
Cliff Emmons, CEO of IIOT-OXYS, Inc., stated, "Now that Chandran Seshagiri, Ph.D., has successfully completed his interim CTO role, he will continue to provide technical guidance as Advisory Board Chairman, as previously announced. Chandran is uniquely qualified to lead our Advisory Board, as he has made significant contributions to our past successful projects and continues to lead our algorithm development efforts on current and future projects. His passion for transforming complex signals into actionable information began with his work at the Harvard-MIT Division of Health Sciences and Technology, where he completed his Ph.D. Chandran's work analyzing physiological time series signals to enable personalized delivery of anesthesia as well as neurostimulation therapy has translated well to the time series data and predictive analyses required for Smart Manufacturing and Structural Health Monitoring applications for IIOT-OXYS, Inc.'s customers."
"As previously stated in our SEC filings, Chandran's CTO role was an interim position for three months," continued Mr. Emmons. "As part of my responsibilities as CEO, I will assume the duties of CTO till we finalize a successor. We are currently in final contract negotiations with an excellent candidate. Our next CTO will reflect the greater focus the Company is placing on Artificial Intelligence (AI) and Machine Learning (ML) in its business model. Our customers value our ability to transform data into actionable insights and is the driving factor for securing new Non-Disclosure Agreements (NDA) earlier this year and has led to several proposals to companies under NDA. An NDA is the first step of our customer engagement process. I and Chandran, in his role as Advisory Board Chairman, will continue building a strong technical relationship with our previously disclosed collaboration partner, Aingura IIoT, S.L. This collaboration, along with the previously disclosed completion of successful pilots with a Fortune 500 Pharma company, and New England state's DOT have allowed the Company and its partner to prepare use cases in smart manufacturing and bridge structural health monitoring respectively, allowing us to renew engagements with all of the Company's earlier prospects and reach out to new ones. Our sales and marketing efforts continue to result in expanding our key targeted markets and serving a diverse group of clients. We expect these agreements to lead to new business in due time."
Forward-Looking Statements
This news release contains forward-looking statements that reflect Management's current views about future events and financial performance. Forward-looking statements often contain words such as ''expects,'' ''anticipates,'' ''intends,'' or ''believes.'' Our forward-looking statements are subject to a number of risks and uncertainties that may cause actual results and events to differ materially from those projected in the forward-looking statements. Risks and uncertainties that could adversely affect us include, without limitation, the loss of major customers, our failure to obtain new contracts, our inability to patent products or processes, our infringement of patents held by others, our inability to finance our business and the other risks and uncertainties that are discussed in our most recent filings with the Securities and Exchange Commission. The forward-looking statements in this news release are made only as of the date of this news release. We undertake no obligation to update our forward-looking statements, whether as a result of new information, future events or otherwise.
About Us
IIOT-OXYS, Inc. is a technology company at the intersection of IIoT, AI & Machine Learning, Edge Computing and Manufacturing Operations. We provide actionable mission-critical insights for the Medical/Pharmaceutical, Manufacturing, Agriculture, Defense, and Structural Health, and other industries. IIOT-OXYS, Inc. edge computing open-source hardware and proprietary ML algorithms employ our Minimally-Invasive Load Monitoring (MILM) technology to simply gather data and gain insights to monitor, scope, move from preventive to predictive maintenance, and even optimize development and manufacturing processes. For additional information visit www.oxyscorp.com
CONTACT:
Clifford L. Emmons
CEO
IIOT-OXYS, Inc.
contact@oxyscorp.com
www.oxyscorp.com
SOURCE: IIOT-OXYS, Inc.
View source version on accesswire.com:
https://www.accesswire.com/654643/IIOT-OXYS-Inc-Announces-Chandran-Seshagiri-Successfully-Completes-CTO-Term-Continues-as-Advisory-Board-Chairman
FAQ
Who is the new Advisory Board Chairman of IIOT-OXYS?
What changes are happening in the leadership of IIOT-OXYS?
What is the focus of IIOT-OXYS moving forward?